---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-176473"
form_type: "8-K"
ticker: "PLRX"
cik: "0001746473"
company_name: "PLIANT THERAPEUTICS, INC."
filed_at: "2022-06-17T23:59:59+00:00"
generated_at: "2026-06-25T00:56:42.656965+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Pliant shareholders re-elect directors, approve say-on-pay at 2022 annual meeting

## Summary
- Shareholders elected John Curnutte (22.7M for) and Smital Shah (22.7M for) as Class II directors.
- Advisory vote on named executive officer compensation passed with 27.9M for, 111.6K against.
- Advisory vote on frequency of future say-on-pay approved with 28.0M favoring one-year interval.
- Ratification of Deloitte & Touche as independent auditor for FY2022 approved with 34.1M for.

## SEC filing metadata
- accession: 0001193125-22-176473
- form_type: 8-K
- ticker: PLRX
- cik: 0001746473
- company_name: PLIANT THERAPEUTICS, INC.
- filed_at: 2022-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1746473/000119312522176473/0001193125-22-176473-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1746473/000119312522176473/d370205d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-176473
- JSON: https://secwatch.observer/filing/0001193125-22-176473.json
- Plain text: https://secwatch.observer/filing/0001193125-22-176473.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.